Patents by Inventor Vinayak Gore

Vinayak Gore has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20180362580
    Abstract: The present disclosure provides crystalline carfilzomib form M1 and a process for the preparation thereof. Further disclosed are processes for the preparation of amorphous carfilzomib using crystalline form M1 as a starting material. The present disclosure also relates to an improved process for the preparation of carfilzomib.
    Type: Application
    Filed: December 10, 2016
    Publication date: December 20, 2018
    Applicant: Mylan Laboratories Limited
    Inventors: Vinayak Gore, Vinay Kumar Shukla, Yogesh Sangvikar, Dattatrey Kokane, Sushant Gharat
  • Publication number: 20180282351
    Abstract: The present disclosure provides amorphous ixazomib citrate and processes for the preparation thereof. Crystalline form M1, form M2, form M3, and form M4 of ixazomib citrate are also disclosed. The present disclosure also encompasses processes for the preparation of those crystalline forms.
    Type: Application
    Filed: September 15, 2016
    Publication date: October 4, 2018
    Applicant: Mylan Laboratories Ltd
    Inventors: Vinayak GORE, Rajesh JOSHI, Anil TRIPATHI, Madhukar PATIL, Ramakoteswara Rao JETTI, Anjaneyaraju INDUKURI, Amit SINGH, Soumyajit GHOSH
  • Publication number: 20180064714
    Abstract: Processes for the preparation of amorphous idelalisib are provided. Processes for the preparation of a premix of amorphous idelalisib are also provided.
    Type: Application
    Filed: March 12, 2016
    Publication date: March 8, 2018
    Inventors: Vinayak GORE, Vinay Kumar SHUKLA, Dattatraya KANKRALE, Shardul BHARATI, Murali BODUPALLI
  • Patent number: 9815789
    Abstract: The present disclosure provides novel crystalline forms of cabozantinib (S)-malate, designated as form-M1, M2, M3 and M4 and novel crystalline forms of cabozantinib free base, form-M1, M2 and M3 and methods of their production. The present disclosure also provides processes for the preparation of crystalline cabozantinib (S)-malate form N-1.
    Type: Grant
    Filed: May 22, 2015
    Date of Patent: November 14, 2017
    Assignee: Mylan Laboratories, Ltd.
    Inventors: Ramakoteswara Rao Jetti, Anjaneyaraju Indukuri, Dnyandeo Punde, Chandersingh Bohra, Mahesh Kumar Gadakar, Vinayak Gore
  • Publication number: 20170096395
    Abstract: The present disclosure provides novel crystalline forms of cabozantinib (S)-malate, designated as form-M1, M2, M3 and M4 and novel crystalline forms of cabozantinib free base, form-M1, M2 and M3 and methods of their production. The present disclosure also provides processes for the preparation of crystalline cabozantinib (S)-malate form N-1.
    Type: Application
    Filed: May 22, 2015
    Publication date: April 6, 2017
    Inventors: Ramakoteswara Rao Jetti, Anjaneyaraju INDUKURI, Dnyandeo PUNDE, Chandersingh BOHRA, Mahesh Kumar GADAKAR, Vinayak GORE
  • Publication number: 20160362391
    Abstract: Methods of synthesizing pomalidomide are disclosed. Further, methods of purifying pomalidomide from a reaction mixture are also disclosed.
    Type: Application
    Filed: November 14, 2014
    Publication date: December 15, 2016
    Inventors: Vinayak Gore, Vinay Kumar Shukla, Dhananjay Shinde, Bansode Prakash
  • Patent number: 9145365
    Abstract: The present invention relates to an improved process for the preparation of Roflumilast. The present invention also relates to crystalline Form-I of Roflumilast.
    Type: Grant
    Filed: May 8, 2014
    Date of Patent: September 29, 2015
    Assignee: Mylan Laboratories Ltd.
    Inventors: Priyesh Vijaykar, Dattatrey Kokane, Sushant Gharat, Dhananjay Shinde, Manojkumar Bindu, Vinayak Gore
  • Publication number: 20140275551
    Abstract: The present invention relates to an improved process for the preparation of Roflumilast. The present invention also relates to crystalline Form-I of Roflumilast.
    Type: Application
    Filed: May 8, 2014
    Publication date: September 18, 2014
    Applicant: MYLAN LABORATORIES LTD.
    Inventors: Priyesh VIJAYKAR, Dattatrey Kokane, Sushant Gharat, Dhananjay Shinde, Manojkumar Bindu, Vinayak Gore
  • Patent number: 8754129
    Abstract: The present invention relates to crystalline forms of the active pharmaceutical ingredient vorinostat, processes for their preparation and their use in pharmaceutical compositions. Formula (I).
    Type: Grant
    Filed: November 25, 2009
    Date of Patent: June 17, 2014
    Assignee: Generics [UK] Limited
    Inventors: Vinayak Gore, Madhukar Patil, Rahul Bhalerao, Hemant Mande
  • Publication number: 20140163241
    Abstract: The present invention relates to two novel crystalline forms of zofenopril calcium, to processes for their preparation and their use in pharmaceutical compositions.
    Type: Application
    Filed: December 12, 2012
    Publication date: June 12, 2014
    Applicant: Generics [UK] Limited
    Inventors: Vinayak Gore, Priyesh Vijayakar
  • Patent number: 8653266
    Abstract: A novel process for the preparation of Etravirine comprises the condensing of ethyl cyanoacetate with N-cyanophenylguanidine to obtain an —OH compound of formula (II), which is further converted to a leaving group of formula (III). The compound of formula (III) is optionally protected and brominated to yield compound of formula (IV). The condensation of formula (IV) with 3,5-dimethyl-4-hydroxybenzonitrile yields a compound of formula (VI), and an optional deprotection of the compound of formula (VI) results in Etravirine.
    Type: Grant
    Filed: April 26, 2012
    Date of Patent: February 18, 2014
    Assignee: Mylan Laboratories Limited
    Inventors: Vinayak Gore, Choudhari Bharati, Mahesh Hublikar, Prakash Bansode, Sandip Sinore
  • Patent number: 8569545
    Abstract: The present invention relates to an improved process for the preparation of (R)-1-aminoindan (2), rasagiline (1) and pharmaceutically acceptable salts of rasagiline.
    Type: Grant
    Filed: June 2, 2009
    Date of Patent: October 29, 2013
    Assignee: Generics (UK) Limited
    Inventors: Vinayak Gore, Bindu Manojkumar, Sandeep Sonawane, Dattatrey Kokane, Sinerpal Tank
  • Publication number: 20130116433
    Abstract: A novel process for the preparation of Etravirine comprises the condensing of ethyl cyanoacetate with N-cyanophenylguanidine to obtain an —OH compound of formula (II), which is further converted to a leaving group of formula (III). The compound of formula (III) is optionally protected and brominated to yield compound of formula (IV). The condensation of formula (IV) with 3,5-dimethyl-4-hydroxybenzonitrile yields a compound of formula (VI), and an optional deprotection of the compound of formula (VI) results in Etravirine.
    Type: Application
    Filed: April 26, 2012
    Publication date: May 9, 2013
    Inventors: Vinayak Gore, Choudhari Bharati, Mahesh Hublikar, Prakash Bansode, Sandip Sinore
  • Publication number: 20120029046
    Abstract: The present invention relates to a novel crystalline form of sunitinib free base designated form I and to processes for its preparation. The invention also relates to its use as an API and in the preparation of various forms of sunitinib. Further, the invention relates to pharmaceutical compositions comprising the novel crystalline form and salts, solvates and hydrates prepared according to the invention, and to the uses of said pharmaceutical compositions in the treatment and/or prevention of cancer.
    Type: Application
    Filed: August 24, 2009
    Publication date: February 2, 2012
    Applicant: Generics (UK) Limited
    Inventors: Vinayak Gore, Bharati Choudhari, Mahesh Hublikar, Prakash Bansode
  • Publication number: 20110269838
    Abstract: The present invention relates to crystalline forms of the active pharmaceutical ingredient vorinostat, processes for their preparation and their use in pharmaceutical compositions.
    Type: Application
    Filed: November 25, 2009
    Publication date: November 3, 2011
    Inventors: Vinayak Gore, Madhukar Patil, Rahul Bhalerao, Hemant Mande
  • Publication number: 20110263718
    Abstract: The present invention provides a convenient and efficient process for the preparation of O-desmethylvenlafaxine (ODV) or a salt thereof, comprising the reaction of venlafaxine, or a salt thereof, with a thiourea or a mixture of thioureas.
    Type: Application
    Filed: July 29, 2009
    Publication date: October 27, 2011
    Applicant: Generics [UK] Limited
    Inventors: Vinayak Gore, Vinay Kumar Shukla, Madhukar Patil
  • Publication number: 20110263670
    Abstract: The present invention relates to novel polymorphs of sunitinib free base designated form II and form III and to processes for their preparation. The invention also relates to their use as APIs and in the preparation of various forms of sunitinib. Further, the invention relates to pharmaceutical compositions comprising said novel polymorphs and salts, solvates and hydrates prepared according to the invention, and to the uses of said pharmaceutical compositions in the treatment and/or prevention of cancer.
    Type: Application
    Filed: August 24, 2009
    Publication date: October 27, 2011
    Inventors: Vinayak Gore, Bharati Choudhari, Mahesh Hublikar, Prakash Bansode
  • Publication number: 20110263713
    Abstract: The present invention relates to crystalline forms of the active pharmaceutical ingredient vorinostat, processes for their preparation and their use in pharmaceutical compositions. Formula (I).
    Type: Application
    Filed: November 25, 2009
    Publication date: October 27, 2011
    Applicant: Mylan India Private Limited
    Inventors: Vinayak Gore, Madhukar Patil, Rahul Bhalerao, Hemant Mande
  • Publication number: 20110263719
    Abstract: The present invention relates to a novel crystalline form of rasagiline mesylate and a pure form of rasagiline mesylate and processes for their preparation. Further, the invention relates to pharmaceutical compositions comprising said forms and use of said compositions in the treatment of patients suffering from Parkinson's Disease, dementia, Alzheimer's Disease, depression, hyperactive syndrome, stroke, brain ischemia, neurotrauma, schizophrenia and multiple sclerosis.
    Type: Application
    Filed: July 29, 2009
    Publication date: October 27, 2011
    Inventors: Vinayak Gore, Bindu Manojkumar, Sandeep Sonawane, Dattatrey Kokane, Sinderpal Tank
  • Publication number: 20110263649
    Abstract: The present invention relates to a novel crystalline form of lenalidomide having formula (I) and chemically known as 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione. The present invention further relates to a process for the preparation of said novel form and its use in pharmaceutical preparations for the treatment of autoimmune disease, inflammation, inflammatory disease and diseases such as cancer, in particular the management of multiple myeloma.
    Type: Application
    Filed: November 2, 2009
    Publication date: October 27, 2011
    Applicant: GENERICS [UK] LIMITED
    Inventors: Priyanka Bhosale, Vinayak Gore, Ashok Pehere, Vinay Shukla